GlassScriptPhysician profile
Mohammed D Ajjan
NPI 1518913003
$984.23
in general payments reported to CMS, 2019-2025
18 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $103 · 2021: $99.31 · 2022: $151 · 2023: $241 · 2024: $147 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $631.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $124.99 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $124.77 | 2023 | Lokelma |
| Janssen Pharmaceuticals, INC | $119.16 | 2023-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $108.94 | 2025 | Assure Wcd |
| Baxter Healthcare | $107.30 | 2021-2024 | Floseal |
| Medtronic USA, INC. | $102.70 | 2020 | |
| Viatris Specialty LLC | $41.67 | 2025 | Yupelri |
| Pfizer INC. | $40.06 | 2025 | |
| Alexion Pharmaceuticals, INC. | $39.78 | 2021 | |
| Abiomed | $26.67 | 2024 | Impella |
| Sk Life Science, INC. | $23.80 | 2021 | |
| Boston Scientific Corporation | $20.84 | 2024 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $20.04 | 2024 | Linq II |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.53 | 2025 | Jardiance |
| Vertex Pharmaceuticals Incorporated | $18.00 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $17.05 | 2021 | |
| Gilead Sciences, INC. | $14.91 | 2025 | Veklury |
| Lemaitre Vascular, INC. | $14.02 | 2023 | Anastoclip Gc 8cm (Medium) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Ajjan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.